tirzepatide sexual function study 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often What to Expect on Tirzepatide:

Instead, adopt a sustainable caloric deficit of 500750 calories (or whatever your healthcare provider recommends) and focus on nutritious foods that fill you up

In addition to the trial results released on April 27, a clinical trial published in the New England Journal of Medicine last year showed that patients who were obese or overweight and had other health conditions such as high blood pressure, high cholesterol, or cardiovascular disease lost 20% of their body weight in 16 months while taking the maximum dose of 15mg

Injectable research studies have similarly reported low rates of adverse events, though this should not be read as a clinical endorsement for any particular use

The only way you'll know is when your experimental results become erratic, inconsistent, or just plain null